Myovant Sciences Ltd. (the company became a subdivision of the company Sumitomo Pharma America, Inc. (SMPA)) (MYOV)
ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
There are no comments here yet...